HBIO

Harvard Bioscience Inc

5.13

USD

HBIO Earnings Reports

Positive Surprise Ratio

HBIO beat 15 of 41 last estimates.

37%

Next Report

Date of Next Report

May 11, 2026

Estimate for Q1 26 (Revenue/ EPS)

$21.62M

-$0.61

Implied change from Q4 25 (Revenue/ EPS)

-8.89%

Implied change from Q1 25 (Revenue/ EPS)

-0.69%

+510.00%

Harvard Bioscience Inc earnings per share and revenue

On Mar 12, 2026, HBIO reported earnings of 0.00 USD per share (EPS) for Q4 25, missing the estimate of 0.35 USD, resulting in a -100.00% surprise. Revenue reached 23.73 million, compared to an expected 23.56 million, with a 0.73% difference. The market reacted with a -2.58% price change (close before vs. close after earnings).

Looking ahead to Q1 26, 4 analysts forecast an EPS of -0.61 USD, with revenue projected to reach 21.62 million USD, implying an -- of --% EPS, and decrease of -8.89% in Revenue from the last quarter.

FAQ

What were Harvard Bioscience Inc's earnings and revenue for the latest quarter Q4 2025?

For Q4 2025, Harvard Bioscience Inc reported EPS of $0.00, missing estimates by -100%, and revenue of $23.73M, 0.73% above expectations.

How did the market react to Harvard Bioscience Inc's Q4 2025 earnings?

The stock price moved down -2.58%, changed from $0.51 before the earnings release to $0.49 the day after.

When is Harvard Bioscience Inc expected to report next?

The next earning report is scheduled for May 11, 2026.

What are the forecasts for Harvard Bioscience Inc's next earnings report?

Based on 4 analysts, Harvard Bioscience Inc is expected to report EPS of -$0.61 and revenue of $21.62M for Q1 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.